Back Dictionary Export CSV
Filter: Clear
ENCORE_PATIENT_ID MERGED_REGIMEN_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION BENCHMARK_GROUP LINK_NUMBER
20216165 20155803 1.76 66.4 Palliative (P) 2017-09-26 2017-10-27 Sorafenib 02 N SORAFENIB 100963750
20216166 20155804 1.74 62.2 null 2019-10-31 2019-11-01 EOX 02 null EOX 101046615
20216172 20155805 1.62 66.9 Palliative (P) 2017-06-23 2017-09-17 EOX 02 N CETUXIMAB + IRINOTECAN + MDG 101758348
20216173 20155806 1.72 86 Palliative (P) 2019-07-17 2019-07-17 FLUOROURACIL + IRINOTECAN + PANITUMUMAB 2 N FLUOROURACIL + IRINOTECAN + PANITUMUMAB 101823820
20216175 20155807 1.64 70 Disease modification (D) 2017-12-22 2017-12-27 Capecitabine 35days + RT N Y EOX 100199795
20216189 20155808 1.5 75.3 Palliative (P) 2019-06-01 2019-08-13 Capecitabine 35days + RT 02 Y CAPECITABINE + RT 101276757
20216191 20155809 1.76 98.9 Palliative (P) 2018-05-12 2018-09-05 Cetuximab + FLUOROURACIL + OXALIPLATIN 02 null CETUXIMAB + FLUOROURACIL + OXALIPLATIN 101295520
20216192 20155810 null null null 2019-12-16 2019-12-23 Capecitabine 35days + RT Y null EOX 101499425
20216194 20155811 1.79 59 Palliative (P) 2018-12-07 2019-01-04 Oxaliplatin + Raltitrexed 02 null OXALIPLATIN + RALTITREXED 100172662
20216195 20155812 1.69 64.4 Palliative (P) 2017-10-24 2017-12-31 IRINOTECAN + MDG + PANITUMUMAB 2 null FLUOROURACIL + IRINOTECAN + PANITUMUMAB 100190030
20216201 20155813 1.63 82.8 null 2020-02-20 2020-03-16 Trial Unspecified 02 Y TRIAL 100154221
20216203 20155814 1.7 78 Palliative (P) 2019-08-16 2019-08-20 Sorafenib 02 N SORAFENIB 101603403
20216207 20155815 1.43 102 Palliative (P) 2018-02-09 2018-02-16 Oxaliplatin + Raltitrexed 02 N OXALIPLATIN + RALTITREXED 101754083
20216208 20155816 1.78 70.5 Palliative (P) 2017-07-29 2017-07-29 Cetuximab + Oxaliplatin + MdG Maint 02 Y CETUXIMAB + FLUOROURACIL + OXALIPLATIN 101215533
20216210 20155817 1.69 107 Neo-adjuvant (N) 2021-01-26 2021-02-04 EOX 02 Y CETUXIMAB + FLUOROURACIL + OXALIPLATIN 101660393
20216213 20155818 1.81 74 Palliative (P) 2020-03-29 2020-03-29 CAPECITABINE + RT 02 N CAPECITABINE + RT 101255452
20216216 20155819 1.57 64.8 Neo-adjuvant (N) 2018-04-30 2018-05-08 FLUOROURACIL + IRINOTECAN + PANITUMUMAB 02 N FLUOROURACIL + IRINOTECAN + PANITUMUMAB 101577149
20216230 20155820 1.87 69.2 Palliative (P) 2017-10-07 2017-10-08 Cetuximab + FOLFIRI cycle 2 onwards 02 N SORAFENIB 100567733
20216239 20155821 1.61 79.6 null 2020-06-12 2020-07-09 EOX 02 N EOX 100410098
20216243 20155822 1.88 18.9 null 2016-11-19 2016-12-17 Cetuximab + Oxaliplatin + MdG Maint 02 null CETUXIMAB + FLUOROURACIL + OXALIPLATIN 101577944
20216244 20155823 1.72 null Palliative (P) 2017-01-22 2017-02-26 EOX 02 null EOX 101755791
20216246 20155824 1.72 78.7 Adjuvant (A) 2016-11-07 2017-02-28 Trial Unspecified 02 Y TRIAL 101591343
20216249 20155826 1.59 74.3 null 2019-09-23 2020-01-01 EOX 02 null CETUXIMAB + IRINOTECAN + MDG 101502443
20216251 20155827 1.69 65.4 Adjuvant (A) 2019-11-17 2019-12-12 Oxaliplatin + Raltitrexed 01 N OXALIPLATIN + RALTITREXED 101145492
20216252 20155828 1.41 72.4 Palliative (P) 2019-01-10 2019-01-10 EOX 02 N EOX 101051557
20216253 20155829 1.81 102.6 Palliative (P) 2020-01-14 2021-08-06 Cetuximab + FLUOROURACIL + OXALIPLATIN 02 null CETUXIMAB + FLUOROURACIL + OXALIPLATIN 100981389
20216254 20155830 1.84 76.3 null 2020-06-26 2020-07-08 EOX 2 null CETUXIMAB + IRINOTECAN + MDG 101682879
20216256 20155831 null null 03 2019-10-19 2019-11-19 Trial Unspecified 02 N TRIAL 101864854
20216261 20155832 1.62 78.4 Palliative (P) 2016-08-25 2016-10-23 Sorafenib 2 N SORAFENIB 101864460
20216262 20155833 1.83 null null 2016-02-23 2016-02-23 Cetuximab + Oxaliplatin + MdG Maint 02 null CETUXIMAB + FLUOROURACIL + OXALIPLATIN 101038159
20216265 20155834 1.75 57.1 Neo-adjuvant (N) 2016-10-22 2016-10-26 Trial Unspecified 01 Y TRIAL 101060287
20216267 20155835 1.64 70.6 Palliative (P) 2020-02-07 2020-02-07 EOX 02 N CETUXIMAB + IRINOTECAN + MDG 101024602
20216273 20155836 1.64 58.1 Palliative (P) 2017-10-12 2017-10-13 CETUXIMAB + IRINOTECAN + MDG N N CETUXIMAB + IRINOTECAN + MDG 100554096
20216275 20155837 1.79 61.9 Palliative (P) 2016-09-28 2016-09-28 EOX 2 N TRIAL 101865503
20216277 20155838 null 61 Palliative (P) 2016-05-10 2016-06-01 CAPECITABINE + RT 02 N CAPECITABINE + RT 101139226
20216278 20155839 1.85 82.5 Palliative (P) 2019-10-08 2019-12-05 Sorafenib 02 N SORAFENIB 100478108
20216281 20155840 1.57 93.3 Neo-adjuvant (N) 2021-02-13 2021-03-06 EOX 02 null CETUXIMAB + FLUOROURACIL + OXALIPLATIN 100245452
20216282 20155841 1.75 80.2 Palliative (P) 2017-05-10 2017-05-10 EOX 1 N EOX 100603460
20216283 20155842 1.69 null Palliative (P) 2017-10-09 2017-10-17 EOX 02 N CAPECITABINE + RT 100093604
20216291 20155843 1.92 69.2 Palliative (P) 2019-06-08 2020-03-27 Oxaliplatin + Raltitrexed 02 N OXALIPLATIN + RALTITREXED 100003848
20216292 20155844 null 107.55 null 2019-04-22 2019-07-15 Sorafenib 02 null SORAFENIB 101681367
20216297 20155845 0 59.1 null null 2019-10-04 Oxaliplatin + Raltitrexed 02 N OXALIPLATIN + RALTITREXED 101358908
20216300 20155846 1.57 null null 2021-04-25 2021-09-05 EOX 02 null EOX 100250445
20216305 20155847 1.75 69.1 Palliative (P) 2019-06-16 2019-07-13 CETUXIMAB + IRINOTECAN + MDG 02 null CETUXIMAB + IRINOTECAN + MDG 100185847
20216307 20155848 1.78 58.8 null 2018-05-13 2019-01-04 Cetuximab + FOLFIRI cycle1 N N CETUXIMAB + IRINOTECAN + MDG 100405386
20216308 20155849 1.6 51.4 null 2019-08-01 2021-12-04 Oxaliplatin + Raltitrexed 02 null OXALIPLATIN + RALTITREXED 101827284
20216310 20155850 0.76 72 Palliative (P) 2018-04-29 2018-05-14 Cetuximab + FOLFIRI cycle 2 onwards 1 null CETUXIMAB + IRINOTECAN + MDG 100933913
20216313 20155851 1.76 107.5 Disease modification (D) 2021-05-27 2021-05-27 Cetuximab + Oxaliplatin + MdG Maint 01 Y CETUXIMAB + FLUOROURACIL + OXALIPLATIN 100925366
20216314 20155852 1.75 90.5 Adjuvant (A) null 2017-10-24 Sorafenib Y N SORAFENIB 100441786
20216318 20155853 1.85 108.8 null 2021-12-23 2022-01-12 Panitumumab + Irinotecan + MdG 02 null FLUOROURACIL + IRINOTECAN + PANITUMUMAB 101819198